Michael Glen Borrus
2 additional attributed investments
Every relationship, signal and contact on this record, with the source on each.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
Nothing material in the last 365 days. Last change: 10 Sep 2012, Latest Cellscape Form D equity offering ($1.1M) on 10 Sep 2012.
Roles
- X/seed Capital Managing MemberJul 1, 2006 to present · “Schedule A: BORRUS, MICHAEL, GLEN, MANAGING MEMBER, since 07/2006, ownership D, control person Y”Fact Form ADV
Investments attributed to this person
| Company | Round | Investor | Attribution | Date | Source |
|---|---|---|---|---|---|
| Cellscape Corp | Form D equity offering · $1.1M | X/seed Capital | strongly supported · board | Sep 10, 2012 | Inference sec.gov |
| VitaPath Genetics, Inc. | Form D equity offering · $4.7M | X/seed Capital | strongly supported · board | May 10, 2012 | Inference sec.gov |
| BIO Architecture Lab Inc | Form D equity offering · $3.0M | X/seed Capital | strongly supported · board | Sep 20, 2011 | Inference sec.gov |
Board seats and vehicles
- Cellscape Corp board seat on a deal Sep 10, 2012 Inference
- VitaPath Genetics, Inc. board seat on a deal May 10, 2012 Inference
- BIO Architecture Lab Inc board seat on a deal Sep 20, 2011 Inference
Timeline
- Sep 10, 2012Form D equity offering in Cellscape Corp (X/seed Capital)
- May 10, 2012Form D equity offering in VitaPath Genetics, Inc. (X/seed Capital)
- Sep 20, 2011Form D equity offering in BIO Architecture Lab Inc (X/seed Capital)
- Jul 1, 2006Joined X/seed Capital as Managing Member